Get the Stockscreener App
27.78
1.68%
0.46
After Hours:
27.78
Staar Surgical Co stock is traded at $27.78, with a volume of 875.11K.
It is up +1.68% in the last 24 hours and up +50.24% over the past month.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
See More
Previous Close:
$27.32
Open:
$27.34
24h Volume:
875.11K
Relative Volume:
0.56
Market Cap:
$1.38B
Revenue:
$224.45M
Net Income/Loss:
$-95.27M
P/E Ratio:
-14.39
EPS:
-1.93
Net Cash Flow:
$-43.74M
1W Performance:
+1.39%
1M Performance:
+50.24%
6M Performance:
+56.51%
1Y Performance:
-11.78%
1-Day Range:
$27.20
$27.79
1-Week Range:
$27.20
$27.84
52-Week Range:
$13.50
$38.60
Staar Surgical Co Stock (STAA) Company Profile
Name
Staar Surgical Co
Sector
Industry
Phone
(626) 303-7902
Address
1911 WALKER AVE, MONROVIA, CA
Compare STAA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
27.78 | 1.37B | 224.45M | -95.27M | -43.74M | -1.93 |
|
ISRG
Intuitive Surgical Inc
|
454.52 | 168.15B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
191.26 | 53.93B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.81 | 39.68B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
78.91 | 38.70B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
247.54 | 17.53B | 2.96B | 487.70M | 344.00M | 6.68 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Wells Fargo | Equal Weight |
| Feb-12-25 | Downgrade | BTIG Research | Buy → Neutral |
| Feb-12-25 | Downgrade | Jefferies | Buy → Hold |
| Feb-12-25 | Downgrade | Mizuho | Outperform → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-15-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jun-11-24 | Upgrade | BTIG Research | Neutral → Buy |
| Mar-11-24 | Upgrade | Stifel | Hold → Buy |
| Dec-05-23 | Downgrade | Needham | Buy → Hold |
| Dec-04-23 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-15-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-03-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jun-07-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-17-23 | Initiated | Piper Sandler | Neutral |
| Feb-06-23 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-28-22 | Reiterated | BTIG Research | Buy |
| Dec-08-22 | Initiated | Stifel | Hold |
| Nov-07-22 | Upgrade | Sidoti | Neutral → Buy |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-28-22 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-18-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-09-21 | Initiated | Oppenheimer | Perform |
| Jan-19-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Oct-26-20 | Downgrade | Sidoti | Buy → Neutral |
| Aug-31-20 | Upgrade | Sidoti | Neutral → Buy |
| Aug-06-20 | Reiterated | The Benchmark Company | Buy |
| Jul-06-20 | Downgrade | Sidoti | Buy → Neutral |
| Jun-24-20 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-15-20 | Initiated | Jefferies | Buy |
| Dec-04-19 | Initiated | BTIG Research | Buy |
| Sep-24-18 | Reiterated | The Benchmark Company | Buy |
| Aug-06-18 | Resumed | The Benchmark Company | Buy |
| Nov-20-17 | Reiterated | The Benchmark Company | Buy |
| Aug-14-17 | Reiterated | The Benchmark Company | Buy |
| Mar-03-17 | Reiterated | The Benchmark Company | Buy |
| May-18-16 | Upgrade | The Benchmark Company | Hold → Buy |
| Sep-10-13 | Resumed | The Benchmark Company | Buy |
| Feb-28-13 | Reiterated | The Benchmark Company | Buy |
| Nov-01-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-12 | Initiated | Northland Securities | Outperform |
| Oct-25-11 | Reiterated | The Benchmark Company | Buy |
| Oct-12-10 | Initiated | Morgan Joseph | Buy |
| May-11-10 | Initiated | Benchmark | Buy |
View All
Staar Surgical Co Stock (STAA) Latest News
Ophthalmic Devices Market Surges to USD 100.2 Billion by 2033, Propelled by 6.4% CAGRVerified Market Reports® - PR Newswire UK
Will STAAR Surgical Company outperform the marketQuarterly Trade Summary & AI Powered Market Entry Ideas - Newser
51% Premium: Eye Surgery Leader STAAR Surgical Backs $28 Per Share Cash Merger with Alcon - Stock Titan
Alcon faces opposition from Staar Surgical’s largest shareholder in planned acquisition - MassDevice
STAAR shareholder Broadwood says it opposes Alcon's proposed takeover - Reuters
STAAR Surgical's largest holder to vote against Alcon bid - MSN
STAAR Surgical’s largest shareholder opposes Alcon takeover - Medical Device Network
Broadwood Announces Intent to Vote Against Acquisition of STAAR Surgical by Alcon - Business Wire
Is STAAR Surgical Company still worth holding after the dip2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Can volume confirm reversal in STAAR Surgical CompanyCEO Change & AI Based Buy and Sell Signals - Newser
Statistical indicators supporting STAAR Surgical Company’s strengthJuly 2025 Trends & Growth Oriented Trade Recommendations - Newser
Risk adjusted return profile for STAAR Surgical Company analyzedWeekly Gains Report & Smart Swing Trading Techniques - Newser
Volume spikes in STAAR Surgical Company stock – what they meanDividend Hike & AI Forecast for Swing Trade Picks - Newser
Applying big data sentiment scoring on STAAR Surgical Company2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Can momentum traders help lift STAAR Surgical CompanyJuly 2025 Sentiment & Expert Curated Trade Ideas - Newser
Chart based exit strategy for STAAR Surgical Company2025 Volatility Report & Real-Time Buy Zone Alerts - Newser
STAAR Surgical's largest holder demands books, records on Alcon deal - MSN
Evaluating STAAR Surgical Company with trendline analysisTake Profit & Precise Swing Trade Entry Alerts - Newser
Using Bollinger Bands to evaluate STAAR Surgical CompanyWeekly Stock Report & Daily Oversold Bounce Ideas - Newser
Is STAAR Surgical Company likely to announce a buyback2025 Support & Resistance & Reliable Momentum Entry Alerts - theviewers.co.kr
What are the future prospects of STAAR Surgical CompanyJuly 2025 Momentum & High Yield Equity Trading Tips - theviewers.co.kr
Is STAAR Surgical Company impacted by rising ratesJuly 2025 Short Interest & Safe Entry Zone Tips - theviewers.co.kr
How moving averages guide STAAR Surgical Company tradingJuly 2025 Decliners & Momentum Based Trading Signals - Newser
Using data tools to time your STAAR Surgical Company exit2025 Biggest Moves & AI Powered Buy/Sell Recommendations - Newser
Can STAAR Surgical Company navigate macro headwindsEarnings Overview Summary & Weekly Watchlist of Top Performers - theviewers.co.kr
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Trapped Investors in STAAR Surgical Company Await Breakout Signal2025 Biggest Moves & Low Drawdown Momentum Ideas - 클래시안
About Us - FinancialContent
Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall - Benzinga
Alcon Q2 2025 slides: Announces $1.5B STAAR acquisition amid softening growth - Investing.com Australia
Alcon Q2 2025 slides: Announces $1.5B STAAR acquisition amid softening growth By Investing.com - Investing.com South Africa
How to interpret RSI for STAAR Surgical Company stockTreasury Yields & AI Powered Market Entry Ideas - Newser
Alcon announces acquisition of STAAR Surgical - MarketScreener
$2.6B Quarter: Eye Care Giant Alcon Expands Empire with STAAR Acquisition and Breakthrough Dry Eye Drug - Stock Titan
Alcon Reports Second-Quarter 2025 Results, Launched Tryptyr and Announced Acquisition of STAAR Surgical - Ariva
How STAAR Surgical Company stock reacts to Fed policy changesJuly 2025 Recap & Community Verified Trade Signals - Newser
Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS - Stock Titan
Midday Stock Roundup: ICU Medical Soars, Willdan Group Down - Orange County Business Journal
1 Unpopular Stock That Deserves Some Love and 2 We Brush Off - Yahoo Finance
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $28 to $28 - 富途牛牛
Penumbra, STAAR Surgical, CONMED, Acadia Healthcare, and Select Medical Shares Are Soaring, What You Need To Know - Yahoo Finance
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Takeover Agreement with Alcon Sparks Sharp Weekly Gains for STAAR Surgical - Insider Monkey
Why STAAR Surgical Company stock attracts strong analyst attentionAI Powered Stock Market Trend Forecast - Newser
11 Best Short-Term Stocks to Invest in - Insider Monkey
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Shareholder Alert: The Ademi Firm Investigates Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders - Bluefield Daily Telegraph
Staar Surgical Co Stock (STAA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):